A Study of LVGN6051 Combined With Anlotinib in Patient With Soft Tissue Sarcoma
Clinical trial NCT05301764 · COMPLETED
Trial details
- NCT number
- NCT05301764
- Sponsor
- Lyvgen Biopharma Holdings Limited
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-25
- Primary completion
- 2025-12-19
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.